Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00089882 · ClinicalTrials.gov registry record
Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II
A clinical trial, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- 360
- Enrollment target
NCT00089882: Completed study, sponsored by National Institute on Aging (NIA).
NCT00089882 is a clinical trial that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 360 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00089882 has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- 360 participants
- Enrollment target
Study Summary
The REVEAL II study provides healthy adult children and siblings of Alzheimer's disease patients with genetic testing and information about their own chances of developing the disease. The study will compare a condensed education and counseling program to the current more extensive program.
Interventions
- PROCEDURE APOE Genetic susceptibility testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2003-05 |
| Est. Completion | 2006-09 |
What the finished NCT00089882 record still lists
NCT00089882 is an observational study that tracks outcomes without assigning an intervention. The registered 360 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which APOE Genetic susceptibility testing is the first listed.
NCT00089882 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00089882 about?
NCT00089882 is a clinical study titled "Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II". The REVEAL II study provides healthy adult children and siblings of Alzheimer's disease patients with genetic testing and information about their own chances of developing the disease. The study will compare a condensed education and counseling program to the current more extensive program.
What is the current status of trial NCT00089882?
This trial is currently completed. The enrollment target is 360 participants. The study started on 2003-05. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00089882?
The interventions under investigation include: APOE Genetic susceptibility testing (PROCEDURE).
Who is sponsoring clinical trial NCT00089882?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747836 · 360 participants
Ultrasound Analysis of Human Carpal Tunnel System
- NCT04089046 · 360 participants · NA
Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)
- NCT04130503 · 360 participants · NA
The Recovery in Stroke Using PAP Study
- NCT04160000 · 360 participants · Phase 4
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia